Medical Condition News

RSS

Elekta awarded delivery of three Leksell Gamma Knife systems to Chinese hospitals

In winning a tender to deliver three Leksell Gamma Knifeâ models to hospitals in China, Elekta will help more cancer patients receive the therapy they need. The agreement also helps Elekta increase its leading market position in China.

From Elekta 2 Nov 2010

NSAIDs drugs prevent colon cancer: Research

Nonsteroidal anti-inflammatory drugs (NSAIDs) prevent colon cancer by triggering diseased stem cells to self-destruct, according to researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine.

2 Nov 2010

$Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients$

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life. So when new, more efficient treatment methods are developed, one important question is whether better treatment comes at the cost of increased side effects and decreased quality of life.

2 Nov 2010

Positive preliminary data from Protalix's taliglucerase alfa switchover trial for Gaucher disease

Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).

2 Nov 2010

Innovative lifesaving device for patients with advanced heart failure

Bradley Cantley, 41, headed home from UC San Diego Medical Center connected to a lifesaving heart machine called a left ventricular assisted device (LVAD). For patients with advanced heart failure, the mechanical pump rapidly improves circulation throughout the body and serves as a bridge to transplant. Cantley is the first of many patients, locally and globally, who will benefit from the expanded heart surgery program at UC San Diego Health System.

2 Nov 2010

Study confirms acupuncture as a viable tool for weight loss

Could a few pinpricks make someone thinner. Evidence weighs heavily in favor of that proposition, according to the results of a new study to be presented at the Pacific Symposium in San Diego this week. The groundbreaking study, "The Effects of Acupuncture on Weight-Loss in Over-Weight and Obese Adults Over 24 Years Old," reports that 95 percent of its subjects lost weight in a six-week period after receiving regular acupuncture treatments. Of those subjects, another 50 percent continued to lose weight after treatments stopped.

2 Nov 2010

FDA selects Rochester to lead initiative to identify improved pain treatments

Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications - opioids and non-steroidal anti-inflammatory drugs (NSAIDS) - have major drawbacks, including the potential for misuse and abuse and adverse effects that limit long-term use. While scientists have made great strides in understanding the physical and chemical processes that occur when people feel pain, new treatments with improved safety and effectiveness are still needed for the more than 76 million Americans with acute and chronic pain.

2 Nov 2010

Experts discuss latest advancements in gynecological diseases at 2nd China Research Forum

DK Sinopharma, Inc. successfully co-hosted the 2nd China Western Gynecological Diseases Research Forum along with China Physician Association Gynecology Branch and Shaanxi Pharmacology Academic Council. Many experts and scholars in gynecology attended the conference, including 146 gynecologists from large hospitals across China.

2 Nov 2010

Older adults are three times as likely to die following ground-level fall

While simple falls, such as slipping while walking off a curb, may seem relatively harmless, they can actually lead to severe injury and death in elderly individuals, according to a new study published in The Journal of Trauma: Injury, Infection, and Critical Care.

2 Nov 2010

Stroke Teams enroll first patient in clinical trial of Penumbra System with Pulse flow restoration device

The Stroke Teams at the University Hospital Dresden in Dresden, Germany, and the University Hospital Göttingen in Göttingen, Germany, have enrolled the first patients in an international clinical trial to assess the safety and effectiveness of aspiration with the Penumbra System in conjunction with the Pulse flow restoration device.

2 Nov 2010

PITs compounds induce cell death and limit tumor growth

A class of compounds that interferes with cell signaling pathways may provide a new approach to cancer treatment, according to a study published online this week in the Proceedings of the National Academy of Sciences (PNAS) Early Edition. The compounds, called PITs (non-phosphoinositide PIP3 inhibitors), limited tumor growth in mice by inducing cell death.

2 Nov 2010

Oxygen Biotherapeutics receives $245,000 grant under PPACA 2010

Oxygen Biotherapeutics, Inc. today announced it has received nearly $245,000 in a grant under the Patient Protection and Affordable Care Program Act of 2010 (PPACA).

2 Nov 2010

GI Dynamics to participate in 2010 Medical Innovation Summit

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that Stuart A. Randle, chief executive officer, will participate in a panel discussion as part of the 2010 Medical Innovation Summit being held at the Cleveland Clinic November 1-3, 2010 in Cleveland, Ohio.

2 Nov 2010

Eli Lilly's new research center to focus on diabetes in China

Eli Lilly and Company announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions.

2 Nov 2010

New REACT medical trial for early diagnosis of lung cancer

Physicians at El Camino Hospital are starting a medical trial called REACT that they hope may give doctors a new and cost-effective tool for early diagnosis of lung cancer, the deadliest of the common cancers.

2 Nov 2010

Research on AID enzyme could improve therapy for lymphoma, leukemia

A recent scientific discovery made by researchers at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Javier Marcelo Di Noia, Director of the Mechanisms and Genetic Diversity research unit, was published online today by The Journal of Experimental Medicine. The team identified a mechanism regulating activation-induced deaminase (AID), which could be important for the therapy of some types of lymphoma and leukemia.

2 Nov 2010

Fitness level, not size or weight, may be more important determinant of women's risk of death

Obesity alone may no longer be linked to a high risk of death in women, according to research published in the Nov. 2010 Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine. Researchers now suggest cardiovascular fitness level, not just a woman's size, may actually be the key predictor of health level and overall risk for death.

2 Nov 2010

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

BioCancell, a developer of anti-cancer drugs, announced success in attaining the goals of its Phase I/IIa clinical trial of BC-819 as a treatment for pancreatic cancer, which demonstrated an excellent safety profile and preliminary efficacy.

2 Nov 2010

Novel technology using quantum dots increases drug uptake in lung injury

Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.

2 Nov 2010

EMA issues Scientific Advice to Genta's clinical development plan for tesetaxel in patients with gastric cancer

Genta Incorporated today announced that the Company has received Scientific Advice from the European Medicines Agency (EMA) on the Company's clinical development plan for tesetaxel in patients with advanced gastric cancer, which includes a pivotal, randomized, controlled, Phase 3 trial.

2 Nov 2010

Medical Condition News

Elekta awarded delivery of three Leksell Gamma Knife systems to Chinese hospitals

NSAIDs drugs prevent colon cancer: Research

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

Positive preliminary data from Protalix's taliglucerase alfa switchover trial for Gaucher disease

Innovative lifesaving device for patients with advanced heart failure

Study confirms acupuncture as a viable tool for weight loss

FDA selects Rochester to lead initiative to identify improved pain treatments

Experts discuss latest advancements in gynecological diseases at 2nd China Research Forum

Older adults are three times as likely to die following ground-level fall

Stroke Teams enroll first patient in clinical trial of Penumbra System with Pulse flow restoration device

PITs compounds induce cell death and limit tumor growth

Oxygen Biotherapeutics receives $245,000 grant under PPACA 2010

GI Dynamics to participate in 2010 Medical Innovation Summit

Eli Lilly's new research center to focus on diabetes in China

New REACT medical trial for early diagnosis of lung cancer

Research on AID enzyme could improve therapy for lymphoma, leukemia

Fitness level, not size or weight, may be more important determinant of women's risk of death

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

Novel technology using quantum dots increases drug uptake in lung injury

EMA issues Scientific Advice to Genta's clinical development plan for tesetaxel in patients with gastric cancer

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News